Global Oncolytic Virus Cancer Immunotherapy Market Growth (Status and Outlook) 2020-2025

Publisher Name :
Date: 07-Apr-2020
No. of pages: 136

According to this study, over the next five years the Oncolytic Virus Cancer Immunotherapy market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Oncolytic Virus Cancer Immunotherapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Oncolytic Virus Cancer Immunotherapy market by type, application, key companies and key regions.

This study considers the Oncolytic Virus Cancer Immunotherapy value generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

- Monoclonal Antibodies

- Checkpoint Inhibitors

- Oncoloytic Viral Therapies and Cancer Vaccines

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

- Lung Cancer

- Breast Cancer

- Colorectal Cancer

- Melanoma

- Prostate Cancer

- Head and neck Cancer

- Ovarian Cancer

- Pancreatic Cancer

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- AstraZeneca

- Crusade Laboratories

- Amgen

- Bristol-Myers Squibb

- Novartis AG

- F Hoffman-La Roche

- Biovex

- Merck & Co., Inc.

- Cell Genesys

- Pfizer

- Genelux Corporation

- MultiVir

- Lokon Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Oncolytic Virus Cancer Immunotherapy market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Oncolytic Virus Cancer Immunotherapy market by identifying its various subsegments.

- Focuses on the key global Oncolytic Virus Cancer Immunotherapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Oncolytic Virus Cancer Immunotherapy with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Oncolytic Virus Cancer Immunotherapy submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Oncolytic Virus Cancer Immunotherapy Market Growth (Status and Outlook) 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Cancer Immunotherapy Market Size 2015-2025
2.1.2 Oncolytic Virus Cancer Immunotherapy Market Size CAGR by Region
2.2 Oncolytic Virus Cancer Immunotherapy Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Monoclonal Antibodies
2.2.3 Oncoloytic Viral Therapies and Cancer Vaccines
2.3 Oncolytic Virus Cancer Immunotherapy Market Size by Type
2.3.1 Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type (2015-2020)
2.3.2 Global Oncolytic Virus Cancer Immunotherapy Market Size Growth Rate by Type (2015-2020)
2.4 Oncolytic Virus Cancer Immunotherapy Segment by Application
2.4.1 Lung Cancer
2.4.2 Breast Cancer
2.4.3 Colorectal Cancer
2.4.4 Melanoma
2.4.5 Prostate Cancer
2.4.6 Head and neck Cancer
2.4.7 Ovarian Cancer
2.4.8 Pancreatic Cancer
2.4.9 Others
2.5 Oncolytic Virus Cancer Immunotherapy Market Size by Application
2.5.1 Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application (2015-2020)
2.5.2 Global Oncolytic Virus Cancer Immunotherapy Market Size Growth Rate by Application (2015-2020)

3 Global Oncolytic Virus Cancer Immunotherapy by Players
3.1 Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Players
3.1.1 Global Oncolytic Virus Cancer Immunotherapy Market Size by Players (2018-2020)
3.1.2 Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Players (2018-2020)
3.2 Global Oncolytic Virus Cancer Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Oncolytic Virus Cancer Immunotherapy by Regions
4.1 Oncolytic Virus Cancer Immunotherapy Market Size by Regions
4.2 Americas Oncolytic Virus Cancer Immunotherapy Market Size Growth
4.3 APAC Oncolytic Virus Cancer Immunotherapy Market Size Growth
4.4 Europe Oncolytic Virus Cancer Immunotherapy Market Size Growth
4.5 Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size Growth

5 Americas
5.1 Americas Oncolytic Virus Cancer Immunotherapy Market Size by Countries
5.2 Americas Oncolytic Virus Cancer Immunotherapy Market Size by Type
5.3 Americas Oncolytic Virus Cancer Immunotherapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Oncolytic Virus Cancer Immunotherapy Market Size by Regions
6.2 APAC Oncolytic Virus Cancer Immunotherapy Market Size by Type
6.3 APAC Oncolytic Virus Cancer Immunotherapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Oncolytic Virus Cancer Immunotherapy by Countries
7.2 Europe Oncolytic Virus Cancer Immunotherapy Market Size by Type
7.3 Europe Oncolytic Virus Cancer Immunotherapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Oncolytic Virus Cancer Immunotherapy by Countries
8.2 Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size by Type
8.3 Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Oncolytic Virus Cancer Immunotherapy Market Forecast
10.1 Global Oncolytic Virus Cancer Immunotherapy Market Size Forecast (2021-2025)
10.2 Global Oncolytic Virus Cancer Immunotherapy Forecast by Regions
10.2.1 Global Oncolytic Virus Cancer Immunotherapy Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Oncolytic Virus Cancer Immunotherapy Forecast by Type
10.8 Global Oncolytic Virus Cancer Immunotherapy Forecast by Application

11 Key Players Analysis
11.1 AstraZeneca
11.1.1 Company Details
11.1.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.1.3 AstraZeneca Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 AstraZeneca News
11.2 Crusade Laboratories
11.2.1 Company Details
11.2.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.2.3 Crusade Laboratories Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Crusade Laboratories News
11.3 Amgen
11.3.1 Company Details
11.3.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.3.3 Amgen Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Amgen News
11.4 Bristol-Myers Squibb
11.4.1 Company Details
11.4.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.4.3 Bristol-Myers Squibb Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Bristol-Myers Squibb News
11.5 Novartis AG
11.5.1 Company Details
11.5.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.5.3 Novartis AG Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Novartis AG News
11.6 F Hoffman-La Roche
11.6.1 Company Details
11.6.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.6.3 F Hoffman-La Roche Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 F Hoffman-La Roche News
11.7 Biovex
11.7.1 Company Details
11.7.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.7.3 Biovex Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Biovex News
11.8 Merck & Co., Inc.
11.8.1 Company Details
11.8.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.8.3 Merck & Co., Inc. Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Merck & Co., Inc. News
11.9 Cell Genesys
11.9.1 Company Details
11.9.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.9.3 Cell Genesys Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Cell Genesys News
11.10 Pfizer
11.10.1 Company Details
11.10.2 Oncolytic Virus Cancer Immunotherapy Product Offered
11.10.3 Pfizer Oncolytic Virus Cancer Immunotherapy Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Pfizer News
11.11 Genelux Corporation
11.12 MultiVir
11.13 Lokon Pharma

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Oncolytic Virus Cancer Immunotherapy Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Monoclonal Antibodies
Table 5. Major Players of Checkpoint Inhibitors
Table 6. Major Players of Oncoloytic Viral Therapies and Cancer Vaccines
Table 7. Oncolytic Virus Cancer Immunotherapy Market Size by Type (2014-2019) ($ Millions)
Table 8. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type (2015-2020)
Table 9. Global Oncolytic Virus Cancer Immunotherapy Market Size by Application (2015-2020) ($ Millions)
Table 10. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application (2015-2020)
Table 11. Global Oncolytic Virus Cancer Immunotherapy Revenue by Players (2018-2020) ($ Millions)
Table 12. Global Oncolytic Virus Cancer Immunotherapy Revenue Market Share by Players (2018-2020)
Table 13. Global Oncolytic Virus Cancer Immunotherapy Key Players Head office and Products Offered
Table 14. Oncolytic Virus Cancer Immunotherapy Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oncolytic Virus Cancer Immunotherapy Market Size by Regions 2015-2020 ($ Millions)
Table 18. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Regions 2015-2020
Table 19. Americas Oncolytic Virus Cancer Immunotherapy Market Size by Countries (2015-2020) ($ Millions)
Table 20. Americas Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Countries (2015-2020)
Table 21. Americas Oncolytic Virus Cancer Immunotherapy Market Size by Type (2015-2020) ($ Millions)
Table 22. Americas Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type (2015-2020)
Table 23. Americas Oncolytic Virus Cancer Immunotherapy Market Size by Application (2015-2020) ($ Millions)
Table 24. Americas Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application (2015-2020)
Table 25. APAC Oncolytic Virus Cancer Immunotherapy Market Size by Regions (2015-2020) ($ Millions)
Table 26. APAC Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Regions (2015-2020)
Table 27. APAC Oncolytic Virus Cancer Immunotherapy Market Size by Type (2015-2020) ($ Millions)
Table 28. APAC Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type (2015-2020)
Table 29. APAC Oncolytic Virus Cancer Immunotherapy Market Size by Application (2015-2020) ($ Millions)
Table 30. APAC Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application (2015-2020)
Table 31. Europe Oncolytic Virus Cancer Immunotherapy Market Size by Countries (2015-2020) ($ Millions)
Table 32. Europe Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Countries (2015-2020)
Table 33. Europe Oncolytic Virus Cancer Immunotherapy Market Size by Type (2015-2020) ($ Millions)
Table 34. Europe Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type (2015-2020)
Table 35. Europe Oncolytic Virus Cancer Immunotherapy Market Size by Application (2015-2020) ($ Millions)
Table 36. Europe Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application (2015-2020)
Table 37. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size by Countries (2015-2020) ($ Millions)
Table 38. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Countries (2015-2020)
Table 39. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size by Type (2015-2020) ($ Millions)
Table 40. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type (2015-2020)
Table 41. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size by Application (2015-2020) ($ Millions)
Table 42. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application (2015-2020)
Table 43. Key and Potential Regions of Oncolytic Virus Cancer Immunotherapy
Table 44. Key Application and Potential Industries of Oncolytic Virus Cancer Immunotherapy
Table 45. Key Challenges of Oncolytic Virus Cancer Immunotherapy
Table 46. Key Trends of Oncolytic Virus Cancer Immunotherapy
Table 47. Global Oncolytic Virus Cancer Immunotherapy Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 48. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share Forecast by Regions
Table 49. Global Oncolytic Virus Cancer Immunotherapy Market Size Forecast by Type (2021-2025) ($ Millions)
Table 50. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share Forecast by Type (2021-2025)
Table 51. Global Oncolytic Virus Cancer Immunotherapy Market Size Forecast by Application (2021-2025) ($ Millions)
Table 52. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share Forecast by Application (2021-2025)
Table 53. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 54. AstraZeneca Oncolytic Virus Cancer Immunotherapy Product Offered
Table 55. AstraZeneca Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 56. AstraZeneca Main Business
Table 57. AstraZeneca Latest Developments
Table 58. Crusade Laboratories Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 59. Crusade Laboratories Oncolytic Virus Cancer Immunotherapy Product Offered
Table 60. Crusade Laboratories Main Business
Table 61. Crusade Laboratories Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 62. Crusade Laboratories Latest Developments
Table 63. Amgen Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 64. Amgen Oncolytic Virus Cancer Immunotherapy Product Offered
Table 65. Amgen Main Business
Table 66. Amgen Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 67. Amgen Latest Developments
Table 68. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 69. Bristol-Myers Squibb Oncolytic Virus Cancer Immunotherapy Product Offered
Table 70. Bristol-Myers Squibb Main Business
Table 71. Bristol-Myers Squibb Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 72. Bristol-Myers Squibb Latest Developments
Table 73. Novartis AG Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 74. Novartis AG Oncolytic Virus Cancer Immunotherapy Product Offered
Table 75. Novartis AG Main Business
Table 76. Novartis AG Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 77. Novartis AG Latest Developments
Table 78. F Hoffman-La Roche Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 79. F Hoffman-La Roche Oncolytic Virus Cancer Immunotherapy Product Offered
Table 80. F Hoffman-La Roche Main Business
Table 81. F Hoffman-La Roche Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 82. F Hoffman-La Roche Latest Developments
Table 83. Biovex Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 84. Biovex Oncolytic Virus Cancer Immunotherapy Product Offered
Table 85. Biovex Main Business
Table 86. Biovex Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 87. Biovex Latest Developments
Table 88. Merck & Co., Inc. Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 89. Merck & Co., Inc. Oncolytic Virus Cancer Immunotherapy Product Offered
Table 90. Merck & Co., Inc. Main Business
Table 91. Merck & Co., Inc. Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 92. Merck & Co., Inc. Latest Developments
Table 93. Cell Genesys Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 94. Cell Genesys Oncolytic Virus Cancer Immunotherapy Product Offered
Table 95. Cell Genesys Main Business
Table 96. Cell Genesys Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 97. Cell Genesys Latest Developments
Table 98. Pfizer Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 99. Pfizer Oncolytic Virus Cancer Immunotherapy Product Offered
Table 100. Pfizer Main Business
Table 101. Pfizer Oncolytic Virus Cancer Immunotherapy Revenue and Gross Margin (2018-2020E)
Table 102. Pfizer Latest Developments
Table 103. Genelux Corporation Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 104. MultiVir Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors
Table 105. Lokon Pharma Details, Company Total Revenue (in $ million), Head Office, Oncolytic Virus Cancer Immunotherapy Major Market Areas and Its Competitors

List of Figures

Figure 1. Oncolytic Virus Cancer Immunotherapy Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Oncolytic Virus Cancer Immunotherapy Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type (2015-2020)
Figure 5. Global Monoclonal Antibodies Market Size Growth Rate
Figure 6. Global Checkpoint Inhibitors Market Size Growth Rate
Figure 7. Global Oncoloytic Viral Therapies and Cancer Vaccines Market Size Growth Rate
Figure 8. Oncolytic Virus Cancer Immunotherapy in Lung Cancer
Figure 9. Global Oncolytic Virus Cancer Immunotherapy Market: Lung Cancer (2015-2020) ($ Millions)
Figure 10. Oncolytic Virus Cancer Immunotherapy in Breast Cancer
Figure 11. Global Oncolytic Virus Cancer Immunotherapy Market: Breast Cancer (2015-2020) ($ Millions)
Figure 12. Oncolytic Virus Cancer Immunotherapy in Colorectal Cancer
Figure 13. Global Oncolytic Virus Cancer Immunotherapy Market: Colorectal Cancer (2015-2020) ($ Millions)
Figure 14. Global Colorectal Cancer YoY Growth ($ Millions)
Figure 15. Oncolytic Virus Cancer Immunotherapy in Melanoma
Figure 16. Global Oncolytic Virus Cancer Immunotherapy Market: Melanoma (2015-2020) ($ Millions)
Figure 17. Global Melanoma YoY Growth ($ Millions)
Figure 18. Oncolytic Virus Cancer Immunotherapy in Prostate Cancer
Figure 19. Global Oncolytic Virus Cancer Immunotherapy Market: Prostate Cancer (2015-2020) ($ Millions)
Figure 20. Global Prostate Cancer YoY Growth ($ Millions)
Figure 21. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application in 2019
Figure 22. Global Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Regions 2015-2020
Figure 23. Americas Oncolytic Virus Cancer Immunotherapy Market Size 2015-2020 ($ Millions)
Figure 24. APAC Oncolytic Virus Cancer Immunotherapy Market Size 2015-2020 ($ Millions)
Figure 25. Europe Oncolytic Virus Cancer Immunotherapy Market Size 2015-2020 ($ Millions)
Figure 26. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size 2015-2020 ($ Millions)
Figure 27. Americas Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Countries in 2019
Figure 28. Americas Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type in 2019
Figure 29. Americas Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application in 2019
Figure 30. United States Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 31. Canada Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 32. Mexico Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 33. APAC Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Regions in 2019
Figure 34. APAC Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type in 2019
Figure 35. APAC Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application in 2019
Figure 36. China Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 37. Japan Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 38. Korea Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 39. Southeast Asia Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 40. India Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 41. Australia Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 42. Europe Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Countries in 2019
Figure 43. Europe Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type in 2019
Figure 44. Europe Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application in 2019
Figure 45. Germany Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 46. France Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 47. UK Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 48. Italy Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 49. Russia Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 50. Spain Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 51. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Countries in 2019
Figure 52. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Type in 2019
Figure 53. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size Market Share by Application in 2019
Figure 54. Egypt Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 55. South Africa Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 56. Israel Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 57. Turkey Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 58. GCC Countries Oncolytic Virus Cancer Immunotherapy Market Size Growth 2015-2020 ($ Millions)
Figure 59. Global Oncolytic Virus Cancer Immunotherapy arket Size Forecast (2021-2025) ($ Millions)
Figure 60. Americas Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 61. APAC Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 62. Europe Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 63. Middle East & Africa Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 64. United States Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 65. Canada Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 66. Mexico Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 67. Brazil Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 68. China Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 69. Japan Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 70. Korea Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 71. Southeast Asia Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 72. India Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 73. Australia Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 74. Germany Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 75. France Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 76. UK Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 77. Italy Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 78. Russia Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 79. Spain Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 80. Egypt Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 81. South Africa Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 82. Israel Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 83. Turkey Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
Figure 84. GCC Countries Oncolytic Virus Cancer Immunotherapy Market Size 2021-2025 ($ Millions)
  • Global Medical Robotics Market (By Segment - Surgical Robotics, Rehabilitation Robotics, Hospital and Pharmacy Robotics, By Application & Region), Key Players Analysis, Trends, Key Industry Developments - Forecast to 2025
    Published: 29-May-2020        Price: US 2190 Onwards        Pages: 258
    The Global Medical Robotics Market is expected to surpass US$ 16 Billion by 2025. Medical robotics can be considered as the application of robotics technology to healthcare to diagnose and treat diseases, or to correct, restore or modify a body function or a body part. With the help of medical robotics, surgeons can carry out operations more precisely and in a less invasive way. It increases the accuracy of the operation with wide range of advantages such as decreased risk of infection, decre......
  • COVID-19 Impact on Electronic Medical Record (EMR) Systems Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 102
    This report covers market size and forecasts of Electronic Medical Record (EMR) Systems, including the following market information: - Global Electronic Medical Record (EMR) Systems Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Electronic Medical Record (EMR) Systems Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Electronic Medical Record (EMR) Systems Market Size by Region (and Key Countries),......
  • COVID-19 Impact on Clinical Chemistry Analyzer Reagents Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 96
    This report covers market size and forecasts of Clinical Chemistry Analyzer Reagents, including the following market information: - Global Clinical Chemistry Analyzer Reagents Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Clinical Chemistry Analyzer Reagents Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Clinical Chemistry Analyzer Reagents Market Size by Region (and Key......
  • COVID-19 Impact on Ankle & Foot Braces Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 91
    This report covers market size and forecasts of Ankle & Foot Braces, including the following market information: - Global Ankle & Foot Braces Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Ankle & Foot Braces Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Ankle & Foot Braces Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (......
  • COVID-19 Impact on Cerebral Oximeters Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 104
    This report covers market size and forecasts of Cerebral Oximeters, including the following market information: - Global Cerebral Oximeters Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Cerebral Oximeters Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Cerebral Oximeters Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Un......
  • COVID-19 Impact on Abdominal Binders Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 98
    This report covers market size and forecasts of Abdominal Binders, including the following market information: - Global Abdominal Binders Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Abdominal Binders Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Abdominal Binders Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)......
  • COVID-19 Impact on Anesthetic Gas Analyzers Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 97
    This report covers market size and forecasts of Anesthetic Gas Analyzers, including the following market information: - Global Anesthetic Gas Analyzers Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Anesthetic Gas Analyzers Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Anesthetic Gas Analyzers Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data......
  • COVID-19 Impact on Cardiac Pressure Monitors Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 92
    This report covers market size and forecasts of Cardiac Pressure Monitors, including the following market information: - Global Cardiac Pressure Monitors Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Cardiac Pressure Monitors Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) - Global Cardiac Pressure Monitors Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly ......
  • COVID-19 Impact on Cardiac Marker Testing Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 96
    This report covers market size and forecasts of Cardiac Marker Testing, including the following market information: - Global Cardiac Marker Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Cardiac Marker Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) - Global Cardiac Marker Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) - Global......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs